SCHEMBL20132408

SCHEMBL20132408

O=C(NO)c1ccc(NC2c3ccccc3-c3ccccc32)cn1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 8/20 0.59
HDAC6 Q9UBN7 8/20 0.59
HDAC1 Q13547 7/20 0.59
HDAC2 Q92769 1/20 0.59
HDAC8 Q9BY41 8/20 0.50
HDAC4 P56524 7/20 0.50
HDAC7 Q8WUI4 1/20 0.41
HDAC9 Q9UKV0 1/20 0.41
HDAC5 Q9UQL6 1/20 0.41
NCOR2 Q9Y618 1/20 0.41
P4HTM Q9NXG6 2/20 0.40
KDM4E B2RXH2 1/20 0.39
NPC1 O15118 1/20 0.39
ALDH1A1 P00352 1/20 0.39
RAB9A P51151 1/20 0.39
KMT2A Q03164 2/20 0.38
MEN1 O00255 1/20 0.38
LMNA P02545 1/20 0.38
PPIA P62937 3/20 0.37
TSHR P16473 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20132409 0.82 MAPK1 (0.48) HDAC3HDAC6HDAC1HDAC2KDM4E
SCHEMBL26699160 0.81 HDAC3 (0.41) HDAC3HDAC6HDAC1HDAC2HDAC8
SCHEMBL1366363 0.74 HDAC6 (1.00) HDAC3HDAC6HDAC1HDAC2
SCHEMBL20160948 0.73 HDAC3 (0.42) HDAC3HDAC6HDAC1HDAC2KMT2A
SCHEMBL20128319 0.69 HDAC1 (0.67) HDAC3HDAC6HDAC1HDAC2HDAC8
SCHEMBL20132421 0.69 HDAC1 (0.61) HDAC3HDAC6HDAC1HDAC2HDAC8
SCHEMBL20132370 0.67 HDAC3 (0.65) HDAC3HDAC6HDAC1HDAC2HDAC8
SCHEMBL26697537 0.67 HDAC3 (0.65) HDAC3HDAC6HDAC1HDAC2HDAC8
SCHEMBL20132366 0.67 HDAC6 (0.59) HDAC3HDAC6HDAC1HDAC2HDAC8
SCHEMBL20132369 0.67 HDAC3 (0.65) HDAC3HDAC6HDAC1HDAC2HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3538084-B1 PHENYL AND PYRIDINYL HYDROXAMIC ACIDS ACETYLON PHARMACEUTICALS INC (US) 2023-11-01 EP disclosed
US-10927072-B2 Phenyl and pyridinyl hydroxamic acids ACETYLON PHARMACEUTICALS, INC. (US) 2021-02-23 US disclosed
US-10370324-B2 Phenyl and pyridinyl hydroxamic acids ACETYLON PHARMACEUTICALS, INC. (US) 2019-08-06 US disclosed
US-20180127356-A1 PHENYL AND PYRIDINYL HYDROXAMIC ACIDS ACETYLON PHARMACEUTICALS, INC. 2018-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10370324-B2 Phenyl and pyridinyl hydroxamic acids HDAC6, HDAC1, HDAC5 HDAC3 4/4885HDAC6 1/4885HDAC1 2/4885
US-10927072-B2 Phenyl and pyridinyl hydroxamic acids HDAC6, HDAC1, HDAC5 HDAC3 4/4885HDAC6 1/4885HDAC1 2/4885
US-20180127356-A1 PHENYL AND PYRIDINYL HYDROXAMIC ACIDS HDAC6, HDAC1, HDAC5 HDAC3 4/4885HDAC6 1/4885HDAC1 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.